TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 153 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $655,000 | -70.6% | 5,814 | -72.6% | 0.00% | -75.0% |
| Q4 2016 | $2,231,000 | -10.1% | 21,195 | -5.7% | 0.02% | -5.9% |
| Q3 2016 | $2,483,000 | +103.7% | 22,466 | +168.4% | 0.02% | +112.5% |
| Q2 2016 | $1,219,000 | -41.0% | 8,370 | -42.0% | 0.01% | -42.9% |
| Q1 2016 | $2,066,000 | +3343.3% | 14,421 | +3636.0% | 0.01% | – |
| Q4 2015 | $60,000 | – | 386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 1,104,168 | $154,849,000 | 80.27% |
| Consonance Capital Management LP | 378,372 | $53,063,000 | 7.89% |
| Moab Capital Partners | 93,133 | $13,061,000 | 6.27% |
| Greywolf Capital Management LP | 277,936 | $38,978,000 | 5.77% |
| Perceptive Advisors | 301,333 | $42,260,000 | 4.15% |
| Valentine Capital Asset Management, Inc. | 141,270 | $19,812,000 | 3.81% |
| Raging Capital Management, LLC | 253,236 | $35,514,000 | 3.78% |
| Ativo Capital Management LLC | 18,058 | $2,532,000 | 1.10% |
| Geduld E E | 8,000 | $1,122,000 | 0.70% |
| Assured Investment Management LLC | 192,389 | $26,981,000 | 0.46% |